THE BI-0115 DIARIES

Rydapt has become shown to improve survival in people with AML affiliated with an FLT3 mutation. Just one major examine, involving 717 these kinds of individuals, compared Rydapt with placebo (a dummy cure) to begin with being an addition to other cancer medicines, accompanied by cure with Rydapt or placebo on your own in Individuals whose disease